Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2003 Nov;62(Suppl 2):ii51–ii54. doi: 10.1136/ard.62.suppl_2.ii51

New strategies to control inflammatory synovitis: interleukin 15 and beyond

I McInnes, J Gracie, M Harnett, W Harnett, F Liew
PMCID: PMC1766739  PMID: 14532150

Full Text

The Full Text of this article is available as a PDF (304.0 KB).

Figure 1.

Figure 1

Open in a new tab

Alternative model approaches, resulting in "proof of concept" clinical studies to target synovitis.

Figure 2.

Figure 2

Open in a new tab

IL15 exhibits pleiotropic effects on numerous target cell types involved in current models of synovitis pathogenesis.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bathon J. M., Martin R. W., Fleischmann R. M., Tesser J. R., Schiff M. H., Keystone E. C., Genovese M. C., Wasko M. C., Moreland L. W., Weaver A. L. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000 Nov 30;343(22):1586–1593. doi: 10.1056/NEJM200011303432201. [DOI] [PubMed] [Google Scholar]
  2. Brennan Fionula M., Hayes Amanda L., Ciesielski Cathleen J., Green Patricia, Foxwell Brian M. J., Feldmann Marc. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis. Arthritis Rheum. 2002 Jan;46(1):31–41. doi: 10.1002/1529-0131(200201)46:1<31::AID-ART10029>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  3. Fehniger T. A., Caligiuri M. A. Interleukin 15: biology and relevance to human disease. Blood. 2001 Jan 1;97(1):14–32. doi: 10.1182/blood.v97.1.14. [DOI] [PubMed] [Google Scholar]
  4. Feldmann M., Brennan F. M., Maini R. N. Rheumatoid arthritis. Cell. 1996 May 3;85(3):307–310. doi: 10.1016/s0092-8674(00)81109-5. [DOI] [PubMed] [Google Scholar]
  5. Ferrari-Lacraz S., Zheng X. X., Kim Y. S., Li Y., Maslinski W., Li X. C., Strom T. B. An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection. J Immunol. 2001 Sep 15;167(6):3478–3485. doi: 10.4049/jimmunol.167.6.3478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grabstein K. H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M. A., Ahdieh M. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 1994 May 13;264(5161):965–968. doi: 10.1126/science.8178155. [DOI] [PubMed] [Google Scholar]
  7. Harada S., Yamamura M., Okamoto H., Morita Y., Kawashima M., Aita T., Makino H. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 1999 Jul;42(7):1508–1516. doi: 10.1002/1529-0131(199907)42:7<1508::AID-ANR26>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  8. Harnett W., Deehan M. R., Houston K. M., Harnett M. M. Immunomodulatory properties of a phosphorylcholine-containing secreted filarial glycoprotein. Parasite Immunol. 1999 Dec;21(12):601–608. doi: 10.1046/j.1365-3024.1999.00267.x. [DOI] [PubMed] [Google Scholar]
  9. Kim Y. S., Maslinski W., Zheng X. X., Stevens A. C., Li X. C., Tesch G. H., Kelley V. R., Strom T. B. Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. J Immunol. 1998 Jun 15;160(12):5742–5748. [PMC free article] [PubMed] [Google Scholar]
  10. Klimiuk P. A., Sierakowski S., Latosiewicz R., Cylwik B., Skowronski J., Chwiecko J. Serum cytokines in different histological variants of rheumatoid arthritis. J Rheumatol. 2001 Jun;28(6):1211–1217. [PubMed] [Google Scholar]
  11. Kotake S., Schumacher H. R., Jr, Yarboro C. H., Arayssi T. K., Pando J. A., Kanik K. S., Gourley M. F., Klippel J. H., Wilder R. L. In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis. Proc Assoc Am Physicians. 1997 May;109(3):286–301. [PubMed] [Google Scholar]
  12. Lawrence R. A., Devaney E. Lymphatic filariasis: parallels between the immunology of infection in humans and mice. Parasite Immunol. 2001 Jul;23(7):353–361. doi: 10.1046/j.1365-3024.2001.00396.x. [DOI] [PubMed] [Google Scholar]
  13. Liew F. Y., McInnes I. B. Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis. 2002 Nov;61 (Suppl 2):ii100–ii102. doi: 10.1136/ard.61.suppl_2.ii100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lipsky P. E., van der Heijde D. M., St Clair E. W., Furst D. E., Breedveld F. C., Kalden J. R., Smolen J. S., Weisman M., Emery P., Feldmann M. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med. 2000 Nov 30;343(22):1594–1602. doi: 10.1056/NEJM200011303432202. [DOI] [PubMed] [Google Scholar]
  15. Ruchatz H., Leung B. P., Wei X. Q., McInnes I. B., Liew F. Y. Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol. 1998 Jun 1;160(11):5654–5660. [PubMed] [Google Scholar]
  16. Scola Michael P., Thompson Susan D., Brunner Hermine I., Tsoras Monica K., Witte David, Van Dijk Marc A., Grom Alexei A., Passo Murray H., Glass David N. Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J Rheumatol. 2002 Feb;29(2):369–378. [PubMed] [Google Scholar]
  17. Sen M., Chamorro M., Reifert J., Corr M., Carson D. A. Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum. 2001 Apr;44(4):772–781. doi: 10.1002/1529-0131(200104)44:4<772::AID-ANR133>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  18. Wakisaka S., Suzuki N., Nagafuchi H., Takeba Y., Kaneko A., Asai T., Sakane T. Characterization of tissue outgrowth developed in vitro in patients with rheumatoid arthritis: involvement of T cells in the development of tissue outgrowth. Int Arch Allergy Immunol. 2000 Jan;121(1):68–79. doi: 10.1159/000024299. [DOI] [PubMed] [Google Scholar]
  19. Waldmann T. A., Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol. 1999;17:19–49. doi: 10.1146/annurev.immunol.17.1.19. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES